Acorda Therapeutics has filed for bankruptcy protection, hoping to keep operating while it tries to arrange the sale of its main assets to a US subsidiary of Germany’s Merz. The announcement ...

Acorda Therapeutics (NASDAQ:ACOR) stock is falling hard on Tuesday after the biopharmaceutical company signed a stalking horse asset purchase agreement with Merz Therapeutics. This agreement will ...

Company Information Company Info Millennials In The Organization Women In The Organization © 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site ...

Dr. Baumgartner joins Applied as an accomplished global drug development leader with over 35 years of experience in senior regulatory, clinical development, and medical affairs roles. He has held a ...